PRKN and metabolic dysfunction-associated steatotic liver disease: Whereas inhibition of the AMPKα1-MFN2 pathway resulted in defective Parkin-mediated mitophagy in NAFLD, which aggravated hepatic fibrosis (Cai et al., 2022).